Recommendations for inclusion or exclusion from the preferred drug list are made at this meeting. Members of the public who wish to testify at this meeting must contact Vern Hamilton at: Vern.Hamilton@ahca.myflorida.com The number of speakers is ...
AGENCY FOR HEALTH CARE ADMINISTRATION
The Medicaid Pharmaceutical and Therapeutics Committee announces a public meeting to which all persons are invited.
DATE AND TIME: Friday, June 19, 2020, 8:30 a.m. – 12:30 p.m.
PLACE: No public face-to-face meeting will take place, join by zoom meeting link at: https://magellanhealth.zoom.us/j/91834362512?pwd=Y2k2QlNhNWtjZFJaUzJtWTVCV1ZpQT09 Or iPhone one-tap (US Toll): (312)626-6799, 91834362512# or (646)558-8656, 91834362512# Or Telephone: Dial: (312)626-6799 (US Toll) or (646)558-8656 (US Toll), Webinar ID: 918 3436 2512
The Executive Session follows the speaker’s portion and is closed to the public. Open session will resume at approximately 10:30 a.m. Use the same zoom link to rejoin the meeting.
GENERAL SUBJECT MATTER TO BE CONSIDERED: Recommendations for inclusion or exclusion from the preferred drug list are made at this meeting. Members of the public who wish to testify at this meeting must contact Vern Hamilton at: Vern.Hamilton@ahca.myflorida.com.
The number of speakers is limited and selection is made by a lottery system. All interested parties must submit details on their speaker to Mr. Hamilton no later than June 9th to be considered for selection by lottery. Because of unforeseen events that may cause changes, please monitor the website at: http://www.ahca.myflorida.com/Medicaid/Prescribed_Drug/meetings.shtml.
A copy of the agenda may be obtained by contacting: Vern.Hamilton@ahca.myflorida.com.
Document Information
- Hearing Meeting:
- No public face-to-face meeting will take place, join by zoom meeting link at: https://magellanhealth.zoom.us/j/91834362512?pwd=Y2k2QlNhNWtjZFJaUzJtWTVCV1ZpQT09 Or iPhone one-tap (US Toll): +13126266799, 91834362512# or +16465588656, 91834362512# Or Telephone: Dial: +1 312 626 6799 (US Toll) or +1 646 558 8656 (US Toll) Webinar ID: 918 3436 2512 The Executive Session follows the speaker’s portion and is closed to the public. Open session will resume at approximately 10:30 a.m. Use the same zoom link to rejoin the meeting.
- Subject:
- Recommendations for inclusion or exclusion from the preferred drug list are made at this meeting. Members of the public who wish to testify at this meeting must contact Vern Hamilton at: Vern.Hamilton@ahca.myflorida.com The number of speakers is limited and selection is made by a lottery system. All interested parties must submit details on their speaker to Mr. Hamilton no later than June 9th to be considered for selection by lottery. Because of unforeseen events that may cause changes, ...
- Meeting:
- public meeting
- Contact:
- Vern.Hamilton@ahca.myflorida.com